End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
2022 | AB-Biotics, S.A. acquired Alifarm S.A. for EUR 3.5 million. | CI |
2019 | Kaneka Europe Holding Company N.V. completed the acquisition of 18.21% stake in AB-Biotics, S.A. | CI |
Sales 2017 | 7.72M 8.36M 698M | Sales 2018 | 12.59M 13.63M 1.14B | Capitalization | 38.75M 41.96M 3.5B |
---|---|---|---|---|---|
Net income 2017 | - 0 0 | Net income 2018 | 1M 1.08M 90.41M | EV / Sales 2017 | 2.22 x |
Net cash position 2017 | 1.86M 2.01M 168M | Net cash position 2018 | 2.44M 2.64M 220M | EV / Sales 2018 | 2.88 x |
P/E ratio 2017 |
-21.2
x | P/E ratio 2018 |
31.7
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 31.56% |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 23/04/23 | |
Founder | - | 23/04/23 | |
Shinji Mizusawa
BRD | Director/Board Member | - | 02/18/02 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 69.57M | |
-27.01% | 9.96B | |
-8.58% | 3.03B | |
+31.86% | 3B | |
-13.62% | 2.18B | |
-16.32% | 1.76B | |
+63.36% | 1.42B | |
+27.00% | 794M | |
-2.18% | 756M | |
+3.18% | 305M |
- Stock Market
- Equities
- ABB Stock